-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Charles River Laboratories International, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Charles River Laboratories International, Inc. Income Tax Expense (Benefit) for the quarter ending June 29, 2024 was $25.4M, a 13.1% decline year-over-year.
- Charles River Laboratories International, Inc. Income Tax Expense (Benefit) for the twelve months ending June 29, 2024 was $94.5M, a 31.3% decline year-over-year.
- Charles River Laboratories International, Inc. annual Income Tax Expense (Benefit) for 2023 was $101M, a 22.6% decline from 2022.
- Charles River Laboratories International, Inc. annual Income Tax Expense (Benefit) for 2022 was $130M, a 59.2% increase from 2021.
- Charles River Laboratories International, Inc. annual Income Tax Expense (Benefit) for 2021 was $81.9M, a 0.08% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)